ERBB2 and gastric cancer: For metastatic and unresectable gastric cancer, radiotherapy, chemotherapy, targeted therapy (HER2/neu [5], VEGFR2 [6], EGFR [7]-based targeted therapy) and immunotherapy are used; however, the prognosis of patients still has much room for improvement [8], as there are still many patients with poor response.